Cleared Traditional

K820945 - SERA FOR ANTINUCLEAR ANTIBODIES

K820945 is an FDA 510(k) clearance for SERA FOR ANTINUCLEAR ANTIBODIES, manufactured by Centers For Disease Control and Prevention. The device is a Class 2 Microbiology device with product code DHN cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K820945 · Centers For Disease Control and Prevention · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1982
Decision
203d
Days
Class 2
Risk

K820945 is an FDA 510(k) clearance for the SERA FOR ANTINUCLEAR ANTIBODIES. Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Centers For Disease Control and Prevention (Walker, US). The FDA issued a Cleared decision on October 26, 1982 after a review of 203 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.5100 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Centers For Disease Control and Prevention devices

FDA 510(k) Submission Details - K820945

510(k) Number K820945 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1982
Decision Date October 26, 1982
Days to Decision 203 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d slower than avg
Panel avg: 102d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHN Device Classification - Class 2, Special Controls

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 60
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K820945.
AFT SYSTEM III
K830214 · Calbiochem-Behring Corp. · Mar 1983
ANTI-NUCLEAR ANTIBODY TEST KIT (ANA)
K822681 · Amico Lab, Inc. · Dec 1982
ANTI-NATIVE (DOUBLE STANDARD) DNA TEST K
K822682 · Amico Lab, Inc. · Dec 1982
ANA HEP-2 FLUORO-KIT
K822397 · Clinical Sciences, Inc. · Sep 1982
QUANTAFLUOR FLUORESCENT TEST REAGENTS
K813592 · Kallestad Laboratories, Inc. · Jan 1982
CRITHIDIA LUCILIAE NATIVE DNA-IFA TEST
K810301 · Immuno Concepts, Inc. · Feb 1981